Bruker Reports 17.4% Revenue Growth in Q2 2024
Bruker sees strong growth in Q2 2024, with strategic acquisitions boosting revenues despite challenges in biopharma and Chinese markets.
- Latest
- Trending
Bruker sees strong growth in Q2 2024, with strategic acquisitions boosting revenues despite challenges in biopharma and Chinese markets.
Discover how Coinbase's new listings of ZetaChain and AVX are causing a surge in these under-the-radar altcoins.
Rocket Lab's Q2 revenue surged 71%, reaching $106M, driven by Electron rocket's successes and Neutron's development progress.
Analyst predicts Bitcoin's rebound to new highs; institutional investments increase, signaling end of correction cycle.
Dogecoin whales invest in Mpeppe, hinting at a potential price surge. Explore why this new coin is attracting major attention.
A bold Ethereum whale invests $1.5M in PEPU and MPEPE, signaling a shift towards emerging meme coins in a volatile ...
Deutsche Telekom reports robust Q2 growth, raises 2024 guidance amidst strategic advancements and enhanced network coverage.
Bragg Gaming Group hits record €24.9M Q2 revenue; strategic US and EU expansion, new leadership drive future growth.
Genpact's Q2 2024 results show 6% revenue rise, fueled by Data-Tech-AI and Digital Operations, boosting future outlook.
Retail investors seize fallen tech stocks, showing caution amid market selloff, with increased interest in safe-haven assets.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.